Agile Therapeutics Inc

NASDAQ:AGRX   3:18:33 PM EDT
1.52
0.00 (+0.33%)
Earnings Announcements

Agile Therapeutics Q1 Net Loss $0.20 Per Share

Published: 05/04/2021 20:40 GMT
Agile Therapeutics Inc (AGRX) - Agile Therapeutics Reports First Quarter 2021 Financial Results.
Agile Therapeutics Inc- Qtrly Net Loss Was $17.1 Million, Or $0.20 per Share.
Revenue is expected to be $4.09 Million
Adjusted EPS is expected to be -$0.18

Next Quarter Revenue Guidance is expected to be $9.25 Million
Next Quarter EPS Guidance is expected to be -$0.14

More details on our Analysts Page.